Abstract:Molecularly targeted therapies are at the forefront of clinical science, and are expected to lead to personalization of medical treatments for each patient. Most such therapies are directed at inhibiting specific signal transduction enzymes or pathways, thus creating a critical need for assays capable of measuring the activities of these proteins in disease models and in patient samples. The ability to measure relevant enzyme activity in primary cell samples at baseline and/or after treatment would provide the ability to tailor patient therapy based on aberrant signal transduction, validate mechanisms of resistance in patients, and would offer an invaluable pharmacodynamic tool to assess whether resistance is associated with inadequate target inhibition. Here we report our most recent efforts to create the analytical and chemical tools needed to directly measure the enzymatic activities of therapeutic targets including protein kinases, lipid-modifying enzymes and the proteasome. Fluorescent reagents are under development that report the activity of these various enzymes with the goal of performing biochemical assays in primary cells. The basic design incorporates enzyme substrates that are modified to create compounds which can be loaded into cells where they are modified by the enzyme of interest. Work has included modification of peptides to confer membrane permeability and to achieve long intracellular lifetimes. Microelectrophoretic separations combined with low-level fluorescence detection enable the quantitative analysis of these compounds from single mammalian cells. This capability addresses three major issues currently faced in the biochemical analysis of clinical samples: the need for direct measurement of the enzymatic activity of target proteins; sample size requirements that are feasible for clinical implementation; and sample heterogeneity that can mask pertinent aspects related to therapeutic response.

Toward Localized In Vivo Biomarker Concentration Measurements

Mapping Metabolic Changes by Noninvasive, Multiparametric, High-Resolution Imaging Using Endogenous Contrast.

Tissue Imaging and Quantification Relying on Endogenous Contrast

In Situ 3D Spatiotemporal Measurement of Soluble Biomarkers in Organoid Culture

Quantitation and localization of protein molecules in living cells

Selected Recent in Vivo Studies on Chemical Measurements in Invertebrates

Insights into <i>In Vivo</i> Environmental Effects on Quantitative Biochemistry in Single Cells

Recent Advances in the Determination of Intracellular Contents in Individual Cells Using Microfluidic Devices

Label-Free Quantification of Molecular Interaction in Live Red Blood Cells by Tracking Nanometer Scale Membrane Fluctuations.

In-Depth Chemical Analysis of the Brain Extracellular Space Using In Vivo Microdialysis with Liquid Chromatography-Tandem Mass Spectrometry

Real-time measurement of small molecules directly in awake, ambulatory animals

From exogenous to endogenous: Advances in in vivo sampling in living systems

Real-Time, In Vivo Molecular Monitoring Using Electrochemical Aptamer Based Sensors: Opportunities and Challenges

Microfluidic Platforms for Real‐Time in Situ Monitoring of Biomarkers for Cellular Processes

Measuring Protein Biomarker Concentrations Using Antibody Tagged Magnetic Nanoparticles.

Targeting the Lowest Concentration of a Toxin That Induces a Detectable Metabolic Response in Living Organisms: Time-Resolved in Vivo 2D NMR During a Concentration Ramp.

Application of in vivo solid phase microextraction in exploring dynamic metabolic alterations in living organisms under exogenous stimulation

Measuring the Enzymatic Activity of Clinically Important Proteins in Single Cells

In vivo biochemistry: applications for small molecule biosensors in plant biology

In Vivo Biomarker Imaging: Paving the Way for Precision Medicine

Enhancement Strategies of Targetability, Response and Photostability for in Vivo Bioimaging